Cargando…
Exposure to depleted uranium does not alter the co-expression of HER-2/neu and p53 in breast cancer patients
BACKGROUND: Amongst the extensive literature on immunohistochemical profile of breast cancer, very little is found on populations exposed to a potential risk factor such as depleted uranium. This study looked at the immunohistochemical expression of HER-2/neu (c-erbB2) and p53 in different histologi...
Autores principales: | Al-Mumen, Mais M, Al-Janabi, Asad A, Jumaa, Alaa S, Al-Toriahi, Kaswer M, Yasseen, Akeel A |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3072333/ https://www.ncbi.nlm.nih.gov/pubmed/21443808 http://dx.doi.org/10.1186/1756-0500-4-87 |
Ejemplares similares
-
High prevalence of HER-2/neu overexpression in female breast cancer among an Iraqi population exposed to depleted uranium
por: AL-Dujaily, Esraa A., et al.
Publicado: (2008) -
Vascular endothelial growth factor (VEGF) receptor expression correlates with histologic grade and stage of colorectal cancer
por: Hashim, Ali F., et al.
Publicado: (2010) -
Increased PTEN gene expression in patients with endometrial carcinoma from areas of high risk depleted uranium exposure
por: Jumaah, Alaa Salah, et al.
Publicado: (2019) -
Specific-mutational patterns of p53 gene in bladder transitional cell carcinoma among a group of Iraqi patients exposed to war environmental hazards
por: Al-Kashwan, Thekra A, et al.
Publicado: (2012) -
Clinical and prognostic profile of Her2neu positive (non-luminal) intrinsic breast cancer subtype: comparison with Her2neu positive luminal breast cancers
por: Hashmi, Atif Ali, et al.
Publicado: (2018)